{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:10:59Z","timestamp":1793661059711,"version":"4.5.1"},"reference-count":344,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"National Science and Technology Council of Taiwan","award":["113\u20132320-B-038\u2013055-MY3"],"award-info":[{"award-number":["113\u20132320-B-038\u2013055-MY3"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/14756366.2025.2489720","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T05:40:30Z","timestamp":1745214030000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as\u00a0prospective cancer therapeutics"],"prefix":"10.1080","volume":"40","author":[{"given":"Ram","family":"Sharma","sequence":"first","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshul","family":"Mishra","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Institute of Biological Chemistry, Academia Sinica","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, ISF College of Pharmacy","place":["Moga, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larasati Vanya","family":"Indira Harahap","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Vanjani","sequence":"additional","affiliation":[{"name":"Molecular Medicine, University of South Florida","place":["Tampa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Hsu","family":"Pan","sequence":"additional","affiliation":[{"name":"Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Nepali","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.002"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/35077232"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08467"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2019.08.023"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1368466"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01379"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182166"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3658"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.5266"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14630"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11111089"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00308-z"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.0c00589"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020489"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115493"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147508"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00541-5"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.30507"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16023202"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.5b00324"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00345-8"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-021-00358-w"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14090876"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113904"},{"issue":"8","key":"e_1_3_5_26_1","first-page":"742","article-title":"Investigation of anti-tumor effects of an MLK1 inhibitor in prostate and pancreatic cancers","volume":"10","author":"Fan Y-C","year":"2021","unstructured":"Fan Y-C, Hsu K-C, Lin T-E, Zechner D, Hsu S-P, Tsai Y-C. Investigation of anti-tumor effects of an MLK1 inhibitor in prostate and pancreatic cancers. Biology (Basel). 2021;10(8):742.","journal-title":"Biology (Basel)"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116454"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.656738"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2020.1843452"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9010092"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.6.2043-2054.2000"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.119016"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092391"},{"issue":"6","key":"e_1_3_5_34_1","first-page":"2590","article-title":"A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K\/AKT\/mTOR\/MEK in multiple cancers","volume":"11","author":"Lawal B","year":"2021","unstructured":"Lawal B, Lo W-C, Mokgautsi N, Sumitra MR, Khedkar H, Wu AT, Huang H-S. A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K\/AKT\/mTOR\/MEK in multiple cancers. Am J Cancer Res. 2021;11(6):2590\u20132617.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2858"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210868"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1087"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10760"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.05.015"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1011"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7792600"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-019-0205-0"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2016.1158362"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01368"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1108297"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3207"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3546"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012716"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.2.708-718.2004"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20415"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0152-0"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410344200"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.13.16305"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00394-2"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00347-10"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1320"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.5101"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/09553008114550651"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(83)90054-4"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(83)90167-9"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji141"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2919"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1383-5742(00)00034-X"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-20-0448"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12912"},{"issue":"12","key":"e_1_3_5_67_1","first-page":"3325","article-title":"Contributions of ATM mutations to familial breast and ovarian cancer","volume":"63","author":"Thorstenson YR","year":"2003","unstructured":"Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muhr D, Wayne TL, Chu G, Davis RW, et\u00a0al. Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res. 2003;63(12):3325\u20133333.","journal-title":"Cancer Res"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-1807"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3386"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.189720"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202541"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8677"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039446"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.275"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.63963"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912710107"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3445"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.10.030"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-022-2585-5"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16462"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167574"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102808"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06911-3"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg2263"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-023-00320-4"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2023.104773"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0435"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2255"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000906"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2024.103803"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49316-8"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-23-0890"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116507"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216642"},{"issue":"6","key":"e_1_3_5_95_1","doi-asserted-by":"crossref","first-page":"e168824","DOI":"10.1172\/jci.insight.168824","article-title":"Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer","volume":"9","author":"Zhang Q","year":"2024","unstructured":"Zhang Q, Jiang L, Wang W, Huber AK, Valvo VM, Jungles KM, Holcomb EA, Pearson AN, The S, Wang Z, et\u00a0al. Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. JCI Insight. 2024;9(6):e168824.","journal-title":"JCI Insight"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00895-6"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S479113"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S31712"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4449"},{"issue":"4","key":"e_1_3_5_100_1","first-page":"367","article-title":"Wortmannin inhibits proliferation and induces apoptosis of MCF-7 breast cancer cells","volume":"33","author":"Yun J","year":"2012","unstructured":"Yun J, Lv Y, Yao Q, Wang L, Li Y, Yi J. Wortmannin inhibits proliferation and induces apoptosis of MCF-7 breast cancer cells. Eur J Gynaec Oncol ISSN. 2012;33(4):367\u2013369.","journal-title":"Eur J Gynaec Oncol ISSN"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10330-010-0715-1"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2727"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5NR05869D"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28185-z"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2018.03.006"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-0707"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39525-3"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920974201"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10084-7"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0286-4"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073834"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.122.001230"},{"key":"e_1_3_5_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114382"},{"key":"e_1_3_5_112_3","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14696"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.103"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0975"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2016-3041"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.680663"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1161-8"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2018-338"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-CT171"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2019-3500"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.123.001971"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2010.09.005"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083430"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.73.011303.073723"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2450"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e08-12-1190"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1382"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601045"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12271-w"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.03.002"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.15.33"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124481"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40578-2"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2011.07.002"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2286"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0286"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0479"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2409"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1257216"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63294-z"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2650"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm990628o"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.243"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01917"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0160"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-1385"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.03.289"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-1026"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.4146"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2021.5263"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00571-y"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-020-01372-y"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-021-09640-x"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12412"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.4025"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568009623666230206143216"},{"key":"e_1_3_5_156_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09431-7"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.290957.116"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.10.009"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005041"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2022.8289"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-23-0402"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01595"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030359"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.12.012"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02935-w"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2076"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.12.001"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0823"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm101520v"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm101488z"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.573"},{"key":"e_1_3_5_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.624"},{"key":"e_1_3_5_173_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.265"},{"key":"e_1_3_5_174_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.21093"},{"key":"e_1_3_5_175_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0110"},{"key":"e_1_3_5_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.09.031"},{"key":"e_1_3_5_177_1","unstructured":"M6620 (VX-970) in Selected Solid Tumors. 2019. https:\/\/clinicaltrials.gov\/study\/NCT03718091."},{"key":"e_1_3_5_178_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.181"},{"key":"e_1_3_5_179_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2158"},{"key":"e_1_3_5_180_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2012-1823"},{"key":"e_1_3_5_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-96121-9.00002-4"},{"key":"e_1_3_5_182_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2013-2348"},{"key":"e_1_3_5_183_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2013-3343"},{"key":"e_1_3_5_184_1","unstructured":"Testing olaparib and AZD6738 in IDH1 and IDH2 mutant tumors. 2020. https:\/\/clinicaltrials.gov\/study\/NCT03878095."},{"key":"e_1_3_5_185_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147817"},{"key":"e_1_3_5_185_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114602"},{"key":"e_1_3_5_186_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19796"},{"key":"e_1_3_5_187_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0685"},{"key":"e_1_3_5_188_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae190"},{"key":"e_1_3_5_189_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS6108"},{"key":"e_1_3_5_190_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19218"},{"key":"e_1_3_5_191_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28551"},{"key":"e_1_3_5_192_1","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2024.2316606"},{"key":"e_1_3_5_193_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2023.09.004"},{"key":"e_1_3_5_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167448"},{"key":"e_1_3_5_195_1","unstructured":"Study of RP-3500 camonsertib in advanced solid tumors. 2020. https:\/\/clinicaltrials.gov\/study\/NCT04497116."},{"key":"e_1_3_5_196_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0615"},{"key":"e_1_3_5_197_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp593"},{"key":"e_1_3_5_198_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-024-04716-x"},{"key":"e_1_3_5_199_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-02951-3"},{"key":"e_1_3_5_200_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad210"},{"key":"e_1_3_5_201_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1707386114"},{"key":"e_1_3_5_202_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-022-00881-w"},{"key":"e_1_3_5_203_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.5.687"},{"key":"e_1_3_5_204_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2004.00162.x"},{"key":"e_1_3_5_205_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R700039200"},{"key":"e_1_3_5_206_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90057-W"},{"key":"e_1_3_5_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2011.02.010"},{"key":"e_1_3_5_208_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42764-021-00047-w"},{"key":"e_1_3_5_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.11.025"},{"key":"e_1_3_5_210_1","article-title":"In-depth mapping of DNA-PKcs signaling uncovers conserved features of its kinase specificity","author":"Marshall S","year":"2024","unstructured":"Marshall S, Navarro MV, Ascen\u04ab\u00e3o CF, Smolka MB. In-depth mapping of DNA-PKcs signaling uncovers conserved features of its kinase specificity. bioRxiv. 2024.300(8):107513.","journal-title":"bioRxiv"},{"key":"e_1_3_5_211_1","doi-asserted-by":"crossref","unstructured":"Gennery A Woodbine L Jeggo P. Reprint of the clinical impact of deficiency in DNA non-homologous end-joining. DNA repair; 2014.","DOI":"10.1016\/j.dnarep.2014.04.002"},{"key":"e_1_3_5_212_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv539"},{"key":"e_1_3_5_213_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00655-1"},{"key":"e_1_3_5_214_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27487"},{"key":"e_1_3_5_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.08.028"},{"key":"e_1_3_5_216_1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.613"},{"issue":"3","key":"e_1_3_5_217_1","first-page":"130","article-title":"DNA double strand break repair via non-homologous end-joining","volume":"2","author":"Davis AJ","year":"2013","unstructured":"Davis AJ, Chen DJ. DNA double strand break repair via non-homologous end-joining. Transl Cancer Res. 2013;2(3):130\u2013143.","journal-title":"Transl Cancer Res"},{"key":"e_1_3_5_218_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107617"},{"key":"e_1_3_5_219_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(98)01232-8"},{"issue":"13","key":"e_1_3_5_220_1","first-page":"2261","article-title":"The effect of DNA-PKcs gene silencing on proliferation, migration, invasion and apoptosis, and in vivo tumorigenicity of human osteosarcoma MG-63 cells. The ATM protein is required for sustained activation of NF-\u03baB following DNA damage","volume":"18","author":"Jin P-Y","year":"2017","unstructured":"(a)Jin P-Y, Lu H-J, Tang Y, Fan S-H, Zhang Z-F, Wang Y, Li X-N, Wu D-M, Lu J, Zheng Y-L, et\u00a0al. The effect of DNA-PKcs gene silencing on proliferation, migration, invasion and apoptosis, and in vivo tumorigenicity of human osteosarcoma MG-63 cells. The ATM protein is required for sustained activation of NF-\u03baB following DNA damage. Oncogene. 2017;18(13):2261\u20132271.","journal-title":"Oncogene"},{"key":"e_1_3_5_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2007.02.007"},{"key":"e_1_3_5_222_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0842"},{"key":"e_1_3_5_223_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123333"},{"key":"e_1_3_5_224_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3137"},{"key":"e_1_3_5_225_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2023.194939"},{"key":"e_1_3_5_226_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115071"},{"key":"e_1_3_5_227_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2020.111692"},{"key":"e_1_3_5_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2024.110183"},{"key":"e_1_3_5_229_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.SABCS-3078"},{"key":"e_1_3_5_230_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.21.1509"},{"key":"e_1_3_5_231_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2785-6"},{"key":"e_1_3_5_232_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0535"},{"key":"e_1_3_5_233_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.07.002"},{"key":"e_1_3_5_234_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7742"},{"key":"e_1_3_5_235_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.07.029"},{"key":"e_1_3_5_236_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2017-4183"},{"key":"e_1_3_5_237_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54796-6"},{"key":"e_1_3_5_238_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04618-5"},{"key":"e_1_3_5_239_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02487-5"},{"key":"e_1_3_5_240_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01082-6"},{"key":"e_1_3_5_241_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0420"},{"key":"e_1_3_5_242_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115629"},{"key":"e_1_3_5_243_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015331"},{"key":"e_1_3_5_244_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114036"},{"key":"e_1_3_5_245_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2024.103689"},{"key":"e_1_3_5_246_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2025.02.001"},{"key":"e_1_3_5_247_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.06.028"},{"key":"e_1_3_5_248_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.01.004"},{"key":"e_1_3_5_249_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155126"},{"key":"e_1_3_5_250_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.10.040"},{"key":"e_1_3_5_251_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1474337"},{"key":"e_1_3_5_252_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2011.06.001"},{"key":"e_1_3_5_253_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2007.109"},{"key":"e_1_3_5_254_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.08.005"},{"key":"e_1_3_5_255_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0683-9"},{"key":"e_1_3_5_256_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.18.6689"},{"key":"e_1_3_5_257_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.03.006"},{"key":"e_1_3_5_258_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114569"},{"key":"e_1_3_5_259_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2010.09.012"},{"key":"e_1_3_5_260_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00447-06"},{"key":"e_1_3_5_261_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007942"},{"key":"e_1_3_5_262_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.20.7305-7314.2003"},{"key":"e_1_3_5_263_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.12.007"},{"key":"e_1_3_5_264_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00472-17"},{"key":"e_1_3_5_265_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.04.018"},{"key":"e_1_3_5_266_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2014.02.020"},{"key":"e_1_3_5_267_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2211"},{"key":"e_1_3_5_268_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e16-01-0032"},{"key":"e_1_3_5_269_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150517"},{"key":"e_1_3_5_270_1","doi-asserted-by":"publisher","DOI":"10.1159\/000493401"},{"key":"e_1_3_5_271_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44771-6"},{"key":"e_1_3_5_272_1","doi-asserted-by":"crossref","unstructured":"(a) Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors and Hematologic Malignancies. https:\/\/clinicaltrials.gov\/study\/NCT01353625.(b) Hui Z Deng H Zhang X Garrido C Lirussi F Ye XY Xie T Liu ZQ. Development and therapeutic potential of DNA-dependent protein kinase inhibitors. Bioorg Chem. 2024:107608.","DOI":"10.1016\/j.bioorg.2024.107608"},{"key":"e_1_3_5_272_2","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S208720"},{"key":"e_1_3_5_273_1","unstructured":"M6620 First in Human Study. 2012. https:\/\/clinicaltrials.gov\/study\/NCT02157792."},{"key":"e_1_3_5_274_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01405-x"},{"key":"e_1_3_5_275_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01406-w"},{"key":"e_1_3_5_276_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-020-04184-z"},{"key":"e_1_3_5_277_1","unstructured":"Study to assess the safety and preliminary efficacy of AZD0156 at increasing doses alone or in combination with other anti-cancer treatment in patients with advanced cancer. 2015. https:\/\/clinicaltrials.gov\/search?cond=NCT02588105."},{"key":"e_1_3_5_278_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-1394"},{"key":"e_1_3_5_279_1","unstructured":"Trial of M4344 and niraparib in patients with poly (ADP-ribose) polymerase (PARP) resistant recurrent ovarian cancer (PARP). 2023. https:\/\/clinicaltrials.gov\/study\/NCT04149145."},{"key":"e_1_3_5_280_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02436-2"},{"key":"e_1_3_5_281_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678707.2017.1304212"},{"key":"e_1_3_5_282_1","unstructured":"A study of LY3023414 in Japanese participants with advanced cancer. 2015. https:\/\/clinicaltrials.gov\/search?cond=NCT02536586."},{"key":"e_1_3_5_283_1","doi-asserted-by":"crossref","unstructured":"(a)Fok JH Ramos-Montoya A Vazquez-Chantada M Wijnhoven PW Follia V James N Farrington PM Karmokar A Willis SE Cairns J. A clinical trial to evaluate AZD7648 alone and in combination with other anti-cancer agents in patients with advanced cancers. https:\/\/clinicaltrials.gov\/study\/NCT03907969. (b) AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation chemotherapy and olaparib activity. Nature Commun. 2019;10(1):5065.","DOI":"10.1038\/s41467-019-12836-9"},{"key":"e_1_3_5_284_1","unstructured":"A platform study of novel agents in combination with radiotherapy in NSCLC (CONCORDE). 2021. https:\/\/clinicaltrials.gov\/study\/NCT04550104?cond=NCT04550104&rank=1."},{"key":"e_1_3_5_285_1","unstructured":"Study of M4344 in combination with niraparib. 2020. https:\/\/clinicaltrials.gov\/study\/NCT04655183."},{"key":"e_1_3_5_286_1","unstructured":"Testing the addition of an anti-cancer drug M3814 (peposertib) to the usual radiation-based treatment (Lutetium Lu 177 Dotatate) for pancreatic neuroendocrine tumors. 2021. https:\/\/clinicaltrials.gov\/study\/NCT04750954."},{"key":"e_1_3_5_287_1","unstructured":"A study combining the peposertib (M3814) pill with standard chemotherapy in patients with ovarian cancer with an expansion in high grade serous ovarian cancer and low grade serous ovarian cancer.2020. https:\/\/clinicaltrials.gov\/study\/NCT04092270."},{"key":"e_1_3_5_288_1","unstructured":"(a) Testing the addition of an anticancer drug BAY 1895344 to the usual chemotherapy with FOLFIRI in advanced or metastatic cancers of the stomach and intestines. 2021. https:\/\/clinicaltrials.gov\/study\/NCT04535401. (b) First-in-human study of ATR inhibitor BAY1895344 in patients with advanced solid tumors and lymphomas. 2017. https:\/\/clinicaltrials.gov\/study\/NCT03188965."},{"key":"e_1_3_5_289_1","unstructured":"Recruiting study of tuvusertib (M1774) in combination with DNA damage response inhibitor or immune checkpoint inhibitor (DDRiver Solid Tumors 320). 2022. https:\/\/clinicaltrials.gov\/search?cond=NCT05396833."},{"key":"e_1_3_5_290_1","unstructured":"(a) A Phase III study of ceralasertib plus durvalumab versus docetaxel in patients with non small cell lung cancer (NSCLC) whose disease progressed on or after prior anti PD (L)1 therapy and platinum based chemotherapy. 2022. https:\/\/clinicaltrials.gov\/study\/NCT05450692. (b) Phase I study to assess safety of AZD6738 alone and in combination with radiotherapy in patients with solid tumours.2014. https:\/\/clinicaltrials.gov\/study\/NCT02223923. (c) Study of AZD6738 DNA damage repair\/novel anti-cancer agent in combination with paclitaxel in refractory cancer. 2015. https:\/\/clinicaltrials.gov\/study\/NCT02630199."},{"key":"e_1_3_5_291_1","unstructured":"Clinical trial of the ATM-inhibitor WSD0628 in combination with radiation therapy for recurrent brain tumors. 2024. https:\/\/clinicaltrials.gov\/search?cond=NCT05917145."},{"key":"e_1_3_5_292_1","unstructured":"Wan L Garg S Hauptschein R Legros P Tardi P Wang L Allen C. Combinations comprising an ATR inhibitor and a PARP inhibitor and methods of use thereof. 2025 WO2025019344."},{"key":"e_1_3_5_293_1","unstructured":"Wan L Garg S Hauptschein R Legros P Tardi P. Methods of use of a liposomal composition comprising an ATR inhibitor to treat cancer. 2025 WO2025019346."},{"key":"e_1_3_5_294_1","unstructured":"Li S Hou S. Five-membered nitrogen-containing heterocyclic and heteroaryl derivative and application as ATR kinase inhibitor. 2023 WO2023020604."},{"key":"e_1_3_5_295_1","unstructured":"Xie Y Liu W Qian L. Naphthyridine derivative as ATR inhibitor and method for preparing same. 2023 WO2023016529."},{"key":"e_1_3_5_296_1","unstructured":"Shan B Hou B Yuwen H Chen P Shi Z Gu Z Chen P Cai Z Mei J. Preparation of heteroaromatic compounds as ATR inhibitors and uses thereof. 2022 WO2022028598."},{"key":"e_1_3_5_297_1","unstructured":"Zheng X Zhao Y Wang H Liu B Zhong W Xu H Huang C Li J Liu W. Preparation of pyrazolopyrimidine compounds as ATR kinase inhibitors. 2023 EP4166556"},{"key":"e_1_3_5_298_1","unstructured":"Li X Chen Y Cai G He F Tao W. Imidazopyrimidine derivative preparation method therefor and medical use thereof. 2020 WO2022002243."},{"key":"e_1_3_5_299_1","unstructured":"Zhao C Wang Z Zhang C Qi F Chen L Jiang C Fan L Chai X Li C Zhang Y. A class of fused ring compounds and preparation and use thereof. 2022 WO2022063303."},{"key":"e_1_3_5_300_1","unstructured":"Yang S Li L. Preparation of quinazoline derivatives as anti-tumor agent. 2021 CN113416181."},{"key":"e_1_3_5_301_1","unstructured":"Qian W Yang C Dai G Li J Chen S. Preparation of quinoline imidazole compound and application thereof. 2021 WO2021139814."},{"key":"e_1_3_5_302_1","unstructured":"Pike KG Barlaam BC Hunt TA Eatherton AJ. Preparation of imidazo[4 5-c]quinolin-2-one compounds and their use in treating cancer. 2017 WO2017076898."},{"key":"e_1_3_5_303_1","unstructured":"Hayakawa M Kaizawa H Kawaguchi K-i Matsuda K Ishikawa N Koizumi T Yamano M Okada M Ohta M. Preparation of imidazopyridine derivatives as phosphatidylinositol 3-kinase inhibitors and anticancer agents. 2001 WO2001083481."},{"key":"e_1_3_5_304_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00519"},{"key":"e_1_3_5_305_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.8b00200"},{"key":"e_1_3_5_306_1","unstructured":"Pike KG Barlaam B Cadogan E Campbell A Chen Y Colclough N Davies NL de-Almeida C Degorce SL Didelot M. The identification of potent selective and orally available inhibitors of ataxia telangiectasia mutated (ATM) kinase: the discovery of AZD0156 (8-{6-[3-(Dimethylamino) propoxy] pyridin-3-yl}-3-methyl-1-(tetrahydro-2\u2009H-pyran-4-yl)-1 3-dihydro-2\u2009H-imidazo [4 5-c] quinolin-2-one). ACS Publications. 2018."},{"key":"e_1_3_5_307_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114234"},{"key":"e_1_3_5_308_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114196"},{"key":"e_1_3_5_309_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c02104"},{"key":"e_1_3_5_310_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00082"},{"key":"e_1_3_5_311_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c02277"},{"key":"e_1_3_5_312_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000006295"},{"key":"e_1_3_5_313_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2015.1019865"},{"key":"e_1_3_5_314_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2548"},{"key":"e_1_3_5_315_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428191003672115"},{"key":"e_1_3_5_316_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00454"},{"key":"e_1_3_5_317_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm301859s"},{"key":"e_1_3_5_318_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114945"},{"key":"e_1_3_5_319_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00734"},{"key":"e_1_3_5_320_1","doi-asserted-by":"crossref","unstructured":"Foote KM Nissink JWM McGuire T Turner P Guichard S Yates JW Lau A Blades K Heathcote D Odedra R. Discovery and characterization of AZD6738 a potent inhibitor of ataxia telangiectasia mutated and Rad3 related (ATR) kinase with application as an anticancer agent. ACS Publications; 2018.","DOI":"10.1021\/acs.jmedchem.8b01187"},{"key":"e_1_3_5_321_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115370"},{"key":"e_1_3_5_322_1","doi-asserted-by":"publisher","DOI":"10.1021\/ml500353p"},{"key":"e_1_3_5_323_1","doi-asserted-by":"publisher","DOI":"10.1021\/ml500352s"},{"key":"e_1_3_5_324_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00426"},{"key":"e_1_3_5_325_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00369"},{"key":"e_1_3_5_326_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114187"},{"key":"e_1_3_5_327_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116159"},{"key":"e_1_3_5_328_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116167"},{"key":"e_1_3_5_329_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm050444b"},{"key":"e_1_3_5_330_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm100608j"},{"key":"e_1_3_5_331_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm400915j"},{"key":"e_1_3_5_332_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm049526a"},{"key":"e_1_3_5_333_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2010.07.066"},{"key":"e_1_3_5_334_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2012.08.035"},{"key":"e_1_3_5_335_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.01.042"},{"key":"e_1_3_5_336_1","first-page":"3461","article-title":"The discovery of 7-methyl-2-[(7-methyl [1, 2, 4] triazolo [1, 5-a] pyridin-6-yl) amino]-9-(tetrahydro-2\u2009H-pyran-4-yl)-7, 9-dihydro-8\u2009H-purin-8-one (AZD7648), a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor","author":"Goldberg FW","year":"2019","unstructured":"Goldberg FW, Finlay MRV, Ting AK, Beattie D, Lamont GM, Fallan C, Wrigley GL, Schimpl M, Howard MR, Williamson B. The discovery of 7-methyl-2-[(7-methyl [1, 2, 4] triazolo [1, 5-a] pyridin-6-yl) amino]-9-(tetrahydro-2\u2009H-pyran-4-yl)-7, 9-dihydro-8\u2009H-purin-8-one (AZD7648), a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor. J Med Chem. 2019.63(7):3461\u20133471.","journal-title":"J Med Chem"},{"key":"e_1_3_5_337_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114401"},{"key":"e_1_3_5_338_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c02231"},{"key":"e_1_3_5_339_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01338"},{"key":"e_1_3_5_340_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00762"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2025.2489720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14756366.2025.2489720","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2025.2489720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:16:34Z","timestamp":1789535794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2025.2489720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":344,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/14756366.2025.2489720"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2025.2489720","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2489720"}}